According to a statement from the pharmaceutical company to the stock exchanges, the Import Alert implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with CGMP standards.
Singapore, July 26 (ANI): Jubilant Pharma Ltd (JPL) will continue to maintain good rating headroom as the impact of a recent US Food and Drug Administration import alert for its generic formulations plant in India will be limited, Fitch Ratings has said.
New Delhi, Aug 8 (ANI): Wockhardt shares slumped 14 percent intraday on Monday after its third plant got US Food and Drugs Administration (FDA) import alert.